Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eylea. Always confirm against the full prescribing information.
5 interactions
Alendronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Alendronic acid.
Level 2 evidence
Ibandronate
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Ibandronate.
Level 2 evidence
Pamidronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Pamidronic acid.
Level 2 evidence
Risedronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Risedronic acid.
Level 2 evidence
Zoledronic acid
The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Zoledronic acid.
Eylea (Aflibercept) has 5 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Eylea (Aflibercept) has 0 major, 5 moderate, and 0 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eylea. Always confirm against the full prescribing information.